U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9801198011Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) PatientsTerminatedNo Results AvailableGraft vs Host DiseaseDrug: Itraconazolehttps://ClinicalTrials.gov/show/NCT01282879
9801298012Hair Count Reduction Verification Study With the LightSheer Duet HS HandpieceCompletedHas ResultsHair RemovalDevice: LightSheer Duethttps://ClinicalTrials.gov/show/NCT01282866
9801398013Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer BleedingCompletedNo Results AvailablePeptic Ulcer|HemorrhageProcedure: endoscopic biopsy|Procedure: endoscopic biopsy|Procedure: endoscopic biopsyhttps://ClinicalTrials.gov/show/NCT01282853
9801498014Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.RecruitingNo Results AvailableLower Urinary Tract SymptomsDrug: Tolterodine SRhttps://ClinicalTrials.gov/show/NCT01282840
9801598015Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve)CompletedNo Results AvailableLow VisionDevice: rtACS (verum condition)|Device: placebo stimulationhttps://ClinicalTrials.gov/show/NCT01282827
9801698016Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle StudyCompletedHas ResultsHealthyDrug: Venlafaxine Hydrochloride|Drug: Effexor® XRhttps://ClinicalTrials.gov/show/NCT01282814
9801798017Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed ConditionsCompletedHas ResultsHealthyDrug: Venlafaxine Hydrochloride|Drug: Effexor® XRhttps://ClinicalTrials.gov/show/NCT01282801
9801898018Efficacy of Caterpillar Cereal for Complementary Feeding in the Democratic Republic of CongoCompletedNo Results AvailableMalnutrition|Stunting of Growth|Iron Deficiency Anemia|Neurodevelopmental Impairment|Infectious Diseases MorbidityDietary Supplement: Caterpillar Cerealhttps://ClinicalTrials.gov/show/NCT01282788
9801998019Interventions to Control Obesity in Community Colleges (CDC WAY to Health)CompletedNo Results AvailableOverweight|ObesityBehavioral: WEB + Environment|Behavioral: WEB + Cash Incentive for Weight Losshttps://ClinicalTrials.gov/show/NCT01282775
9802098020Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCompletedNo Results AvailableChronic Kidney DiseaseBiological: HEPLISAV|Biological: Engerix-Bhttps://ClinicalTrials.gov/show/NCT01282762
9802198021Effectiveness of SisterTalk Hartford for Weight Loss Among African-American WomenCompletedNo Results AvailableOverweight|ObesityBehavioral: SisterTalk Hartford|Behavioral: Attention control video serieshttps://ClinicalTrials.gov/show/NCT01282749
9802298022Guided Self-Help for Binge Eating DisorderActive, not recruitingNo Results AvailableBinge Eating DisorderBehavioral: Integrative Response Therapy|Behavioral: Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT01282736
9802398023Multi-Reader Multi-Case Study to Identify Uterine Contractions Recorded From Laboring Patients by Practicing CliniciansCompletedHas ResultsPregnancy - Labor Monitoringhttps://ClinicalTrials.gov/show/NCT01282723
9802498024Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant WomenCompletedHas ResultsPregnancy - Labor Monitoringhttps://ClinicalTrials.gov/show/NCT01282710
9802598025Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid TumorsNot yet recruitingNo Results AvailableRefractory Solid Tumors in ChildrenDrug: Combined administration of irinotecan and rapamycinhttps://ClinicalTrials.gov/show/NCT01282697
9802698026Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: PLX5622|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01282684
9802798027Effects of Deep Breathing Exercises Two Months After Cardiac SurgeryCompletedNo Results AvailableCABG|Valve SurgeryOther: Breathing exerciseshttps://ClinicalTrials.gov/show/NCT01282671
9802898028Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRCRecruitingNo Results AvailableColorectal Cancerhttps://ClinicalTrials.gov/show/NCT01282658
9802998029Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 YearsWithdrawnNo Results AvailableE04.525.190|Craniotomy|CraniectomyDevice: PSI in PEEKhttps://ClinicalTrials.gov/show/NCT01282645
9803098030Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNo Results AvailableSubjects Had Unipolar, Non-psychotic Major DepressionDrug: Risperidone|Drug: Olanzapinehttps://ClinicalTrials.gov/show/NCT01282632
9803198031Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's DiseaseDrug: Huperzine A|Drug: huperzine A|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01282619
9803298032Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc HerniationCompletedNo Results AvailableLumbar Vertebra HerniaDrug: SI-6603https://ClinicalTrials.gov/show/NCT01282606
9803398033Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).RecruitingNo Results AvailableAcute Lymphoblastic Leukemia (ALL)Other: Impact of CD9 expression level on motility assays|Other: Post-transcriptional regulation of CD9https://ClinicalTrials.gov/show/NCT01282593
9803498034Dietary Fish and Omega 3 Fatty Acids for Breast Cancer PreventionCompletedNo Results AvailableBreast CancerDietary Supplement: Lovaza-Omega 3 fatty acid capsules|Other: Dietary fish (canned salmon, albacore)https://ClinicalTrials.gov/show/NCT01282580
9803598035Study for the Artificial Pancreas Project : Determination of a Tuning Strategy of Metabolic ProfilesCompletedNo Results AvailableType 1 DiabetesOther: Blood sampleshttps://ClinicalTrials.gov/show/NCT01282567
9803698036Evaluation of Electrostimulation Program During Dialysis Sessions in Chronic Renal Failure PatientsCompletedNo Results AvailableChronic Renal Failure (CRF)Device: electrostimulation program (Rehab 400)https://ClinicalTrials.gov/show/NCT01282554
9803798037Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With EpiphoraCompletedNo Results AvailableEpiphoraDrug: Botulinum Toxin Type A|Drug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT01282541
9803898038Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid ArthritisRecruitingNo Results AvailableRheumatoid Arthritis|Ultrasonography|InfliximabBiological: infliximabhttps://ClinicalTrials.gov/show/NCT01282528
9803998039Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDTActive, not recruitingNo Results AvailableGenital Erosive Lichen PlanusDrug: clobetasolpropionate|Drug: hexaminolevulinatehttps://ClinicalTrials.gov/show/NCT01282515
9804098040Midostaurin (PKC412) for Locally Advanced Rectal CancerRecruitingNo Results AvailableAdenocarcinoma of the RectumDrug: Midostaurinhttps://ClinicalTrials.gov/show/NCT01282502

* Görseller ve İçerik tekif hakkına sahip olabilir